Patent details

EP2444079 Title: Compositions and Methods for Treatment of Eye Disorders

Basic Information

Publication number:
EP2444079
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP111810669
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Compositions and Methods for Treatment of Eye Disorders
French Title of Invention:
Compositions et procédés pour le traitement des troubles de l'oeil
German Title of Invention:
Zusammensetzungen und Verfahren zur Behandlung von Augenerkrankungen
SPC Number:

Dates

Filing date:
17/05/2006
Grant date:
30/11/2016
EP Publication Date:
30/11/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/04/2012
EP B1 Publication Date:
30/11/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
17/05/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
28/11/2023
 
 

Name:
BAUSCH + LOMB IRELAND LIMITED
Address:
Citywest Business Campus, 3013 Lake Drive, Dublin 24, Ireland (IE)

History of Owners

From:
09/04/2020
To:
28/11/2023

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

From:
17/05/2006
To:
09/04/2020

Name:
SARcode Bioscience Inc.
Address:
1000 Marina Blvd., Suite 250, Brisbane, CA 94005, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
18/01/2017
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
Gadek Thomas
Address:
United States (US)

2

Name:
Burnier John
Address:
United States (US)

Priority

1

Priority Number:
681772 P
Priority Date:
17/05/2005
Priority Country:
United States (US)

2

Priority Number:
681722 P
Priority Date:
17/05/2005
Priority Country:
United States (US)

3

Priority Number:
681723 P
Priority Date:
17/05/2005
Priority Country:
United States (US)

4

Priority Number:
681684 P
Priority Date:
17/05/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/166;

Publication

Bulletin

1

Bulletin Heading:
CO
Bulletin edition number:
2020/06
Publication date:
07/05/2020
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

2

Bulletin Heading:
CO
Bulletin edition number:
2023/13
Publication date:
07/12/2023
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20200000109A
Date Registered:
09/04/2020
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Removed Pledgee

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20230000496A
Date Registered:
28/11/2023
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
BAUSCH + LOMB IRELAND LIMITED
Address:
Citywest Business Campus, 3013 Lake Drive, Dublin 24, Ireland (IE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
23/04/2025
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
28/11/2023 Request For Change 54
29/11/2023 Outgoing Correspondence 1
09/04/2020 Request For Change 46
18/01/2017 Power Of Attorney 1
15/04/2020 Outgoing Correspondence 1